Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chimu Fuyanning Capsule in Pelvic Inflammatory Disease Sequelae
CTR20132127Phase 2Active
- Sponsor
- Wuhan Pharmaceutical Valley Technology Development
- Start
- Feb 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chimu fuyanning in Pelviabdominal infection, sponsored by Wuhan Pharmaceutical Valley Technology Development. Started Feb 2014; status: active.
02
Drugs
chimu fuyanning
03
Conditions
Pelviabdominal infection
Beyond the preview
Go deeper on CTR20132127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132127.